Sonnet BioTherapeutics logo

Sonnet BioTherapeutics Employee Directory

Biotechnology ResearchNew Jersey, United States11-50 Employees

Sonnet BioTherapeutics is a Princeton, New Jersey-based biotechnology company focused on cytokine biology. Its clinical program comprises five cytokine-derived therapeutic candidates, led by SON-1010 in Phase 1 and SON-080 in Phase 1b/2a, with three additional candidates in preclinical development. The firm positions its work primarily within immune oncology, while suggesting potential applications across a broader spectrum of diseases.

The FHAB platform centers on a mechanism that binds albumin in the bloodstream to extend exposure and improve delivery of the active drug to target tissues, including tumors. Preclinical data indicate substantial improvements in both half-life and efficacy compared with non-albumin-binding cytokines, supporting the potential for combination strategies in cancer immunotherapy. In October 2024, Sonnet BioTherapeutics announced a collaboration with Alkem Laboratories to develop and commercialize SON-080 for diabetic peripheral neuropathy in India.

Find Sonnet BioTherapeutics employees' phone numbers or email addresses

Sonnet BioTherapeutics Global Highlights

Location
Employees

North America
12

Minus sign iconPlus sign icon
  • United States Of America
    12

Sonnet BioTherapeutics's Leadership

  • Director Board Of Directors at Sonnet BioTherapeutics
    L. M.
    Director Board Of Directors
  • Contractor at Sonnet BioTherapeutics
    R. R.
    Contractor

Sonnet BioTherapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Entrepreneurship
  • Accounting
  • Other

Contact profiles from Sonnet BioTherapeutics

Name
Title
Contact
Location
Last Update
  • Director Board Of Directors at Sonnet BioTherapeutics
    L. M.
    Director Board Of Directors
    Jun 28, 2026
  • Contractor at Sonnet BioTherapeutics
    R. R.
    Contractor
    Oct 21, 2024

Frequently Asked Questions

What is Sonnet BioTherapeutics known for?

Minus sign iconPlus sign icon
Sonnet BioTherapeutics was founded in 2011 and operates in the Biotechnology Research industry. You can contact Sonnet BioTherapeutics's main corporate office by phone at . Explore Sonnet BioTherapeutics's company overview page for more information.

What is Sonnet BioTherapeutics's most common email format?

Minus sign iconPlus sign icon
Sonnet BioTherapeutics employees' email format typically follows the pattern of FirstLast@sonnetbio.com. Trying to find reliable and up-to-date employee contact data? Find more Sonnet BioTherapeutics email formats with LeadIQ.

How many employees does Sonnet BioTherapeutics have currently?

Minus sign iconPlus sign icon
Sonnet BioTherapeutics has approximately 11 employees as of August 2026. These team members are located across 1 continents, including North America.

Who are Sonnet BioTherapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Sonnet BioTherapeutics's key employees include:

  • Director Board Of Directors: L. M.
  • Contractor: R. R.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.